Amneal to Participate at Upcoming Investor Conference

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will present at the Barclays 27th Annual Global Healthcare Conference on March, 12, 2025. Chirag Patel, Co-Chief Executive Officer and President, will participate in a fireside chat at 11:00 AM ET. A live webcast of the fireside chat will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250310797554/en/

Investor Contact
Anthony DiMeo
VP, Investor Relations
[email protected]

Source: Amneal Pharmaceuticals, Inc.

You May Also Be Interested In

• Amneal Pharmaceuticals (AMRX) PT Raised to $25 at UBS on Near Term Growth Drivers
• HSBC Continental Europe: Availability of the First Amendment to the Universal Registration Document Including the 2026 Half-Year Financial Report
• LOS ANGELES AUTO SHOW® TICKETS NOW ON SALE: TEN DAYS, HUNDREDS OF NEW VEHICLES AND UNLIMITED TEST DRIVES FOR SOCAL